Sanofi Ventures Team
Photo of Laia Crespo, Investor at Sanofi Ventures
Laia Crespo
Sanofi Ventures·Investor
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Paris (France), Investors in Cambridge (MA)
Photo of Cris De Luca, Partner at Sanofi Ventures
Cris De Luca
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Paris (France), Investors in Israel, Investors in New York (NY), Investors in Europe, Investors in San Francisco (CA), Investors in Cambridge (MA)
Investors in AR/VR (Series A), Investors in AR/VR (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in IoT (Series B), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in Pharmaceuticals (Series B), Investors in Diverse Investors (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Investors who were founders (Other Lists), Investors in Health IT (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Israel (Other Lists), Investors in AI (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists), Investors in AR/VR (Series A), Investors in AR/VR (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in AR/VR (Series A), Investors in AI (Series A), Investors in AR/VR (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in Consumer Health (Series A), Investors in AI (Series A), Investors in Consumer Health (Series A), Investors in IoT (Series A), Investors in IoT (Series A), Investors in Health IT (Series A), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in IoT (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in AR/VR (Series B), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in AR/VR (Series B), Investors in Pharmaceuticals (Series A), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in Consumer Health (Series B), Investors in AI (Series B), Investors in Consumer Health (Series B), Investors in AR/VR (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in AI (Series B), Investors in AR/VR (Series B), Investors in IoT (Series B), Investors in Health IT (Series B), Investors in Health IT (Series B), Investors in IoT (Series B), Investors in IoT (Series B), Investors in IoT (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Digital Health (Series A)
Photo of Christopher Gagliardi, Investor at Sanofi Ventures
Christopher Gagliardi
Sanofi Ventures·Investor
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Paris (France), Investors in Cambridge (MA)
Photo of Jason P. Hafler, Managing Director at Sanofi Ventures
Jason P. Hafler
Sanofi Ventures·Managing Director
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Paris (France), Investors in Cambridge (MA)
Photo of Meg Krench, Investor at Sanofi Ventures
Meg Krench
Sanofi Ventures·Investor
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Paris (France), Investors in Cambridge (MA)
Photo of Camille Ridel, Investor at Sanofi Ventures
Camille Ridel
Sanofi Ventures·Investor
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Paris (France), Investors in Cambridge (MA)
Photo of Jim Trenkle, Investor at Sanofi Ventures
Jim Trenkle
Sanofi Ventures·Investor
Sweet spot: $7.5M
Range: $5.0M - $10.0M
Investors in Paris (France), Investors in Cambridge (MA)